Literature DB >> 12165852

Several regions of p53 are involved in repression of RNA polymerase III transcription.

Torsten Stein1, Diane Crighton, Lorna J Warnock, Jo Milner, Robert J White.   

Abstract

The tumour suppressor p53 has been shown to regulate RNA polymerase (pol) III transcription both in vitro and in vivo. We have characterized the regions of p53 that contribute to this effect. Repression of pol III transcription in vivo does not require residues 13-19 near the N-terminus of p53 that are highly conserved through evolution. However, amino acids 22 and 23 in the adjacent transactivation domain do contribute to the inhibition of pol III activity. Deletions within the central DNA-binding core domain (residues 102-292) of p53 can entirely abolish the repression function in these assays, despite the fact that pol III templates contain no recognized p53 binding site. Deletion or substitution within the C-terminal domain of p53 can also compromise its ability to repress pol III activity in vitro and in transfected cells. These observations reveal that repression of pol III transcription is a complex function involving multiple regions of p53 extending throughout much of the protein.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165852     DOI: 10.1038/sj.onc.1205739

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding.

Authors:  Anastasia A Gridasova; R William Henry
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Gender Specific Differences in RNA Polymerase III Transcription.

Authors:  N Diette; J Koo; S Cabarcas-Petroski; L Schramm
Journal:  J Carcinog Mutagen       Date:  2016-01-29

Review 3.  Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors.

Authors:  Yong-Yu Liu
Journal:  Cancer Res       Date:  2011-10-04       Impact factor: 12.701

4.  p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB.

Authors:  Diane Crighton; Annette Woiwode; Cheng Zhang; Nihar Mandavia; Jennifer P Morton; Lorna J Warnock; Jo Milner; Robert J White; Deborah L Johnson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

Review 5.  Transcriptional regulation of human small nuclear RNA genes.

Authors:  Gauri W Jawdekar; R William Henry
Journal:  Biochim Biophys Acta       Date:  2008-04-08

6.  Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.

Authors:  A Veronese; F Pepe; J Chiacchia; S Pagotto; P Lanuti; S Veschi; M Di Marco; A D'Argenio; I Innocenti; B Vannata; F Autore; M Marchisio; D Wernicke; F Verginelli; G Leone; L Z Rassenti; T J Kipps; R Mariani-Costantini; L Laurenti; C M Croce; R Visone
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

7.  The green tea component EGCG inhibits RNA polymerase III transcription.

Authors:  Joby Jacob; Stephanie Cabarcas; Ingrid Veras; Nurulain Zaveri; Laura Schramm
Journal:  Biochem Biophys Res Commun       Date:  2007-07-02       Impact factor: 3.575

8.  Impact of Alu repeats on the evolution of human p53 binding sites.

Authors:  Feng Cui; Michael V Sirotin; Victor B Zhurkin
Journal:  Biol Direct       Date:  2011-01-06       Impact factor: 4.540

Review 9.  RNA polymerase III transcription in cancer: the BRF2 connection.

Authors:  Stephanie Cabarcas; Laura Schramm
Journal:  Mol Cancer       Date:  2011-04-25       Impact factor: 27.401

10.  Differential expression of the TFIIIB subunits Brf1 and Brf2 in cancer cells.

Authors:  Stephanie Cabarcas; Joby Jacob; Ingrid Veras; Laura Schramm
Journal:  BMC Mol Biol       Date:  2008-08-12       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.